Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
02/01/2016 02/02/2016 02/03/2016 02/04/2016 02/05/2016 Date
264.3(c) 260.7(c) 257.3(c) 253.5(c) 252.2(c) Last
1 732 542 1 707 858 1 916 829 2 132 956 1 930 603 Volume
+0.15% -1.36% -1.30% -1.48% -0.51% Change
More quotes
Financials ( CHF)
Sales 2016 51 250 M
EBIT 2016 18 005 M
Net income 2016 11 803 M
Debt 2016 9 384 M
Yield 2016 3,41%
Sales 2017 54 222 M
EBIT 2017 19 694 M
Net income 2017 12 992 M
Debt 2017 4 066 M
Yield 2017 3,68%
P/E ratio 2016 17,91
P/E ratio 2017 16,19
EV / Sales 2016 4,43x
EV / Sales 2017 4,09x
Capitalization 217 506 M
More Financials
Company
Roche Holding AG operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics.It operates business through two divisons: Pharmaceuticals and Diagnostics.The Pharmaceuticals divison comprises the two business segments Roche Pharmaceuticals and Chugai,... 
Sector
Pharmaceuticals
Calendar
03/01Shareholder meeting
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
02/03 Seven $1 billion-plus drugs seen reaching market in 2016
01/28 Oil climbs on hopes for output cut, dollar slips
01/28 Roche annual profit disappoints, outlook muted
01/28DJRoche Profit Dented by Strong Swiss Franc -- 2nd Update
01/28DJU.S. Stocks Climb, Along With Oil
01/28DJRoche Profit Dented by Strong Swiss Franc -- Update
01/28DJRoche Profit Dented by Strong Swiss Franc
01/28DJROCHE : Profit Dented by Strong Swiss Franc
More news
Sector news : Pharmaceuticals - NEC
02/05 SANOFI : Muzammil Mansuri is Sanofi’s new Executive Committee member
02/05 SANOFI : Zealand clarifies its role in US patent litigation relating to lixisena..
02/05 H LUNDBECK A/S : FDA Psychopharmacologic Drug Advisory Committee supports the ef..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
02/02 Pacific Biosciences jumps 24% on report of Roche buyout interest
01/31 Questioning The Bearish Narrative Surrounding NewLink's IMPRESS Trial
01/29 Drug Pricing In The U.S. Under Pressure From Multiple Fronts - Is It Time To ..
01/28 Roche Holding's (RHHBY) CEO Severin Schwan on Q4 2015 Results - Earnings Call..
01/28 REGENERON - A REVIEW : Strong Returns Look Likely For 2016 And Beyond


Comments 
Advertisement
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Full-screen chart
Technical analysis trends ROCHE HOLDING LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions